Latest News

STAT Plus: Pharmalittle: Trump backs off a drug pricing proposal; lawmakers ask HHS for documents on Gilead’s HIV prevention pill

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest. We plan to catch up on our reading, promenade our official mascot, hang with our short people, and take a long leisurely drive through barren back roads. And what about you? This is a lovely time to enjoy the great outdoors. You could get around to that spring cleaning you postponed or make time for someone special. If you feel brave enough, you could also calculate how much those tariffs will cost you. Well, whatever you do, have a grand time, but be safe. Enjoy, and see you soon. …

Two Democratic lawmakers asked the Department of Health and Human Services to provide documents concerning government patents held on the Truvada HIV prevention pill sold by Gilead Sciences (GILD), as well as documents relating to an agreement reached with the drug maker to donate its medicine. The request was just after the House Committee on Oversight and Government Reform held a hearing to explore the role the government played in discovering Truvada and the high cost of the medicine.

Continue to STAT Plus to read the full story…

Source link

Related posts

Warning about making health decisions based on 'over the counter' genetic tests


Number of UK adults on low incomes who face hunger has likely almost doubled since 2004


How This Tree From Northeast Brazil Rains Nectar


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy